We are live on ! Find out more
BAY

BAYER AG SPONS ADR
BAY

Delisted

BAY was delisted on the 26th of September, 2007.

17 hedge funds and large institutions have $34M invested in BAYER AG SPONS ADR in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

49% more capital invested

Capital invested by funds: $22.8M → $34M (+$11.2M)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

6% more funds holding

Funds holding: 1617 (+1)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.27%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
4
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

BAY Hedge Fund Activity: Q1 2023 in Review

17 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in BAYER AG SPONS ADR (BAY) for Q1 2023, worth a combined $34M — up 49% from $22.8M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BAY positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Pacer Advisors, adding an estimated $5.44M. The largest seller was NorthCrest Asset Manangement, exiting entirely with an estimated $335K sold.

  • 17 institutional investors held BAYER AG SPONS ADR (BAY) as of Q1 2023, up from 16 in Q4 2022.
  • Funds reported $34M of BAYER AG SPONS ADR stock for Q1 2023, up 49% quarter-over-quarter.
  • 4 funds opened new BAYER AG SPONS ADR positions in Q1 2023 and 2 closed out, a net change of +2 holders.
  • The largest BAYER AG SPONS ADR buyer in Q1 2023 was Pacer Advisors, an estimated $5.44M added.
  • The largest BAYER AG SPONS ADR seller in Q1 2023 was NorthCrest Asset Manangement, an estimated $335K sold.

Based on aggregated 13F filings for Q1 2023.